Novo Nordisk CEO Lars Fruergaard Jørgensen has agreed to voluntarily testify in September before the Senate’s health ...
Bernie Sanders has called a vote to subpoena a Novo Nordisk executive to testify on the company’s prices for Ozempic and ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
The Senate HELP Committee, chaired by Sen. Bernie Sanders, has subpoenaed a pharmaceutical company’s president over ...
the CEO of Novo Nordisk will testify before lawmakers later this year on the "outrageously high cost" of the company's diabetes and weight-loss drugs—Ozempic and Wegovy ... a letter announcing an ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Sanders drops subpoena threat against Novo Nordisk Sen. Bernie Sanders (I-Vt.), chairman of ...
Novo Nordisk charges Americans with obesity $1,349 a month for Wegovy, while this same exact product can be purchased for just $92 in the United Kingdom, $186 in Denmark, and $265 in Canada. (The net ...
Sanders’ initiative comes seven weeks after the HELP Committee launched an investigation into Novo’s prices ... medicine Ozempic in the U.S. versus $155 monthly in Canada, $122 in Denmark and $59 in ...
While Novo Nordisk charges $1,349 a month for Wegovy ... system for the high prices of its top-selling weight-loss drugs Wegovy and Ozempic, following the launch of an investigation into the ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, announced Tuesday he will hold a vote on issuing a subpoena for a top Novo Nordisk executive to ...
Senator Bernie Sanders launched an investigation into the “unacceptable, outrageously high” prices of Ozempic and Wegovy, two GLP-1 weight loss and diabetes medications that have soared in ...